Conmed (CNMD) Tops Q2 EPS by 1c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil prices steady as investors weigh US-Iran war escalation
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
CONMED Corporation Announces Second Quarter 2018 Financial Results
August 1, 2018 4:01 PM EDTUTICA, N.Y.--(BUSINESS WIRE)-- CONMED Corporation (Nasdaq: CNMD) today announced financial results for the second quarter ended June 30, 2018.
Second Quarter 2018 Highlights
Sales of $212.8 million increased 7.9% year over year as reported and 7.4% in constant currency and as adjusted(1). Domestic revenue increased 9.6% year over year as reported and 12.0% as adjusted(1). International revenue increased 6.2% as reported and 2.9% in constant currency. Gross margin (GAAP) increased 150 basis points and adjusted gross margin increased 190 basis points year over year to... More